Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial.
Ntuku H, Smith-Gueye C, Scott V, Njau J, Whittemore B, Zelman B, Tambo M, Prach LM, Wu L, Schrubbe L, Kang Dufour MS, Mwilima A, Uusiku P, Sturrock H, Bennett A, Smith J, Kleinschmidt I, Mumbengegwi D, Gosling R, Hsiang M. Ntuku H, et al. Among authors: prach lm. BMJ Open. 2022 Jun 23;12(6):e049050. doi: 10.1136/bmjopen-2021-049050. BMJ Open. 2022. PMID: 35738650 Free PMC article. Clinical Trial.
Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
Medzihradsky OF, Kleinschmidt I, Mumbengegwi D, Roberts KW, McCreesh P, Dufour MK, Uusiku P, Katokele S, Bennett A, Smith J, Sturrock H, Prach LM, Ntuku H, Tambo M, Didier B, Greenhouse B, Gani Z, Aerts A, Gosling R, Hsiang MS. Medzihradsky OF, et al. Among authors: prach lm. BMJ Open. 2018 Jan 27;8(1):e019294. doi: 10.1136/bmjopen-2017-019294. BMJ Open. 2018. PMID: 29374672 Free PMC article. Clinical Trial.
Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
Hsiang MS, Ntuku H, Roberts KW, Dufour MK, Whittemore B, Tambo M, McCreesh P, Medzihradsky OF, Prach LM, Siloka G, Siame N, Gueye CS, Schrubbe L, Wu L, Scott V, Tessema S, Greenhouse B, Erlank E, Koekemoer LL, Sturrock HJW, Mwilima A, Katokele S, Uusiku P, Bennett A, Smith JL, Kleinschmidt I, Mumbengegwi D, Gosling R. Hsiang MS, et al. Among authors: prach lm. Lancet. 2020 Apr 25;395(10233):1361-1373. doi: 10.1016/S0140-6736(20)30470-0. Lancet. 2020. PMID: 32334702 Free PMC article. Clinical Trial.
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.
Vilakati S, Mngadi N, Benjamin-Chung J, Dlamini N, Dufour MK, Whittemore B, Bhangu K, Prach LM, Baltzell K, Nhlabathi N, Malambe C, Dlamini B, Helb D, Greenhouse B, Maphalala G, Pindolia D, Kalungero M, Tesfa G, Gosling R, Ntshalintshali N, Kunene S, Hsiang MS. Vilakati S, et al. Among authors: prach lm. BMJ Glob Health. 2021 Jun;6(6):e005021. doi: 10.1136/bmjgh-2021-005021. BMJ Glob Health. 2021. PMID: 34193475 Free PMC article. Clinical Trial.
Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial.
Wu L, Hsiang MS, Prach LM, Schrubbe L, Ntuku H, Dufour MK, Whittemore B, Scott V, Yala J, Roberts KW, Patterson C, Biggs J, Hall T, Tetteh KKA, Gueye CS, Greenhouse B, Bennett A, Smith JL, Katokele S, Uusiku P, Mumbengegwi D, Gosling R, Drakeley C, Kleinschmidt I. Wu L, et al. Among authors: prach lm. EClinicalMedicine. 2022 Feb 14;44:101272. doi: 10.1016/j.eclinm.2022.101272. eCollection 2022 Feb. EClinicalMedicine. 2022. PMID: 35198913 Free PMC article.
Targeted malaria elimination interventions reduce Plasmodium falciparum infections up to 3 kilometers away.
Benjamin-Chung J, Li H, Nguyen A, Heitmann GB, Bennett A, Ntuku H, Prach LM, Tambo M, Wu L, Drakeley C, Gosling R, Mumbengegwi D, Kleinschmidt I, Smith JL, Hubbard A, van der Laan M, Hsiang MS. Benjamin-Chung J, et al. Among authors: prach lm. medRxiv [Preprint]. 2023 Nov 30:2023.09.19.23295806. doi: 10.1101/2023.09.19.23295806. medRxiv. 2023. Update in: Nat Med. 2024 Oct;30(10):2813-2820. doi: 10.1038/s41591-024-03134-z PMID: 37790419 Free PMC article. Updated. Preprint.
Extension of efficacy range for targeted malaria-elimination interventions due to spillover effects.
Benjamin-Chung J, Li H, Nguyen A, Barratt Heitmann G, Bennett A, Ntuku H, Prach LM, Tambo M, Wu L, Drakeley C, Gosling R, Mumbengegwi D, Kleinschmidt I, Smith JL, Hubbard A, van der Laan M, Hsiang MS. Benjamin-Chung J, et al. Among authors: prach lm. Nat Med. 2024 Oct;30(10):2813-2820. doi: 10.1038/s41591-024-03134-z. Epub 2024 Jul 4. Nat Med. 2024. PMID: 38965434 Free PMC article. Clinical Trial.
Post-treatment duration of positivity for standard and ultra-sensitive Plasmodium falciparum antigen-based rapid diagnostic tests, a cohort study from a low-endemic setting in Namibia.
Ntuku H, Whittemore B, Dausab L, Jang IK, Golden A, Sheahan W, Wu X, Slater H, Domingo GJ, Das S, Duarte E, Eloff L, Bousema T, Lanke K, Gueye CS, Prach LM, Raman J, Uusiku P, Katokele S, Gosling R, Greenhouse B, Mumbengegwi D, Hsiang MS. Ntuku H, et al. Among authors: prach lm. EBioMedicine. 2024 Dec 9;111:105489. doi: 10.1016/j.ebiom.2024.105489. Online ahead of print. EBioMedicine. 2024. PMID: 39657364 Free PMC article.
19 results